Neomycin and Polymyxin B sulfates and Hydrocortisone

Product NDC
81607-014
Requested package NDC
81607-014-10
11-digit product format
816070014
Labeler code
81607
Product ID
81607-014_d432f97b-7f75-4a04-96a7-de9c9124824c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Neomycin and Polymyxin B sulfates and Hydrocortisone
Dosage form
SOLUTION/ DROPS
Route
AURICULAR (OTIC)
Labeler
Orbicular Pharmaceutical Technologies Private Limited
Application
ANDA220938
Marketing category
ANDA
Marketing start
2026-10-08
Substance
NEOMYCIN SULFATE; POLYMYXIN B SULFATE; HYDROCORTISONE
Active strength
3.5; 10000; 10 mg/mL; [iU]/mL; mg/mL
Pharmacologic classes
Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220938-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONEHYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSOLUTION/DROPS / OTICAT2026-08-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A220938-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220938-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSOLUTION/DROPS / OTICAT2026-08-27d4dbc9d85df4…
2026-10-15 13:18:302026-09A220938-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSOLUTION/DROPS / OTICAT2026-08-27c2088c7a36db…
2026-09-14 22:38:342026-08A220938-001NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE1%;EQ 3.5MG BASE/ML;10,000 UNITS/MLSOLUTION/DROPS / OTICAT2026-08-2784e616aacf4f…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220938-001AT1d4dbc9d85df4…
2026-10-15 13:18:302026-09A220938-001AT1c2088c7a36db…
2026-09-14 22:38:342026-08A220938-001AT184e616aacf4f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Neomycin and Polymyxin B sulfates and Hydrocortisone
Brand name suffix
OTIC
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NEOMYCIN SULFATE3.5 mg/mL
POLYMYXIN B SULFATE10000 [iU]/mL
HYDROCORTISONE10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
057Y626693Internal UNII lookup
19371312D4Internal UNII lookup
WI4X0X7BPJInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
204423Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5eae31aa-ec63-4b93-9859-8d718a8ac8efAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Neomycin and Polymyxin B sulfates and Hydrocortisone OTICNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONEOrbicular Pharmaceutical Technologies Private Limited5eae31aa-ec63-4b93-9859-8d718a8ac8ef2026-10-14Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220938
application number: ANDA220938
ndc (package): 81607-014-10
ndc (product): 81607-014
ndc11 (package): 81607001410
Neomycin and Polymyxin B sulfates and Hydrocortisone OTICNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONEHikma Pharmaceuticals USA Inc.2846b507-f92d-45e0-9807-f68bdf4de56c2026-09-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220938
application number: ANDA220938

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
81607-014-10816070014101 BOTTLE, DROPPER in 1 CARTON (81607-014-10) / 10 mL in 1 BOTTLE, DROPPER2026-10-08NoNoCurrent